Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020005720> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2020005720 endingPage "121" @default.
- W2020005720 startingPage "120" @default.
- W2020005720 abstract "The irreversible ErbB family blocker afatinib and the reversible EGFR tyrosine kinase inhibitor gefitinib were compared in the multicenter, international, randomized, head-to-head phase 2b LUX-Lung 7 trial for first-line treatment of advanced EGFR mutation–positive NSCLCs. Afatinib and gefitinib costs and patients’ outcomes in France were assessed.A partitioned survival model was designed to assess the cost-effectiveness of afatinib versus gefitinib for EGFR mutation–positive NSCLCs. Outcomes and safety were taken primarily from the LUX-Lung 7 trial. Resource use and utilities were derived from that trial, an expert-panel questionnaire, and published literature, limiting expenditures to direct costs. Incremental cost-effectiveness ratios (ICERs) were calculated over a 10-year time horizon for the entire population, and EGFR exon 19 deletion or exon 21 L858R mutation (L858R) subgroups. Deterministic and probabilistic sensitivity analyses were conducted.For all EGFR mutation–positive NSCLCs, the afatinib-versus-gefitinib ICER of was €45,211 per quality-adjusted life-year (QALY) (0.170 QALY gain for an incremental cost of €7697). ICERs for EGFR exon 19 deletion and L858R populations were €38,970 and €52,518, respectively. Afatinib had 100% probability to be cost-effective at a willingness-to-pay threshold of €70,000/QALY for patients with common EGFR mutations.First-line afatinib appears cost-effective compared with gefitinib for patients with EGFR mutation–positive NSCLCs." @default.
- W2020005720 created "2016-06-24" @default.
- W2020005720 creator A5003326735 @default.
- W2020005720 creator A5075501393 @default.
- W2020005720 creator A5086741053 @default.
- W2020005720 creator A5091043812 @default.
- W2020005720 date "2010-06-01" @default.
- W2020005720 modified "2023-10-14" @default.
- W2020005720 title "472 Interaction of ephrinB2 with its receptors EphB4 and EphB6 – potential impact on tumour-associated inflammation in human melanoma" @default.
- W2020005720 doi "https://doi.org/10.1016/s1359-6349(10)71273-8" @default.
- W2020005720 hasPublicationYear "2010" @default.
- W2020005720 type Work @default.
- W2020005720 sameAs 2020005720 @default.
- W2020005720 citedByCount "0" @default.
- W2020005720 crossrefType "journal-article" @default.
- W2020005720 hasAuthorship W2020005720A5003326735 @default.
- W2020005720 hasAuthorship W2020005720A5075501393 @default.
- W2020005720 hasAuthorship W2020005720A5086741053 @default.
- W2020005720 hasAuthorship W2020005720A5091043812 @default.
- W2020005720 hasConcept C121608353 @default.
- W2020005720 hasConcept C126322002 @default.
- W2020005720 hasConcept C143998085 @default.
- W2020005720 hasConcept C2776256026 @default.
- W2020005720 hasConcept C2779438470 @default.
- W2020005720 hasConcept C2780580887 @default.
- W2020005720 hasConcept C2780586478 @default.
- W2020005720 hasConcept C2908647359 @default.
- W2020005720 hasConcept C71924100 @default.
- W2020005720 hasConcept C99454951 @default.
- W2020005720 hasConceptScore W2020005720C121608353 @default.
- W2020005720 hasConceptScore W2020005720C126322002 @default.
- W2020005720 hasConceptScore W2020005720C143998085 @default.
- W2020005720 hasConceptScore W2020005720C2776256026 @default.
- W2020005720 hasConceptScore W2020005720C2779438470 @default.
- W2020005720 hasConceptScore W2020005720C2780580887 @default.
- W2020005720 hasConceptScore W2020005720C2780586478 @default.
- W2020005720 hasConceptScore W2020005720C2908647359 @default.
- W2020005720 hasConceptScore W2020005720C71924100 @default.
- W2020005720 hasConceptScore W2020005720C99454951 @default.
- W2020005720 hasIssue "5" @default.
- W2020005720 hasLocation W20200057201 @default.
- W2020005720 hasOpenAccess W2020005720 @default.
- W2020005720 hasPrimaryLocation W20200057201 @default.
- W2020005720 hasRelatedWork W2049303357 @default.
- W2020005720 hasRelatedWork W2128885041 @default.
- W2020005720 hasRelatedWork W2810945895 @default.
- W2020005720 hasRelatedWork W2888534976 @default.
- W2020005720 hasRelatedWork W2906574801 @default.
- W2020005720 hasRelatedWork W3042289395 @default.
- W2020005720 hasRelatedWork W3149574443 @default.
- W2020005720 hasRelatedWork W3175282903 @default.
- W2020005720 hasRelatedWork W4281690819 @default.
- W2020005720 hasRelatedWork W1931533321 @default.
- W2020005720 hasVolume "8" @default.
- W2020005720 isParatext "false" @default.
- W2020005720 isRetracted "false" @default.
- W2020005720 magId "2020005720" @default.
- W2020005720 workType "article" @default.